Gene amplification and protein overexpression of EGFR and ERBB2 in sinonasal squamous cell carcinoma

Abstract

A substantial proportion of SNSCCs carried alterations in EGFR or ERBB2. Together with the absence of KRAS mutations, these findings indicate that therapies targeting these molecules may be promising additions to the therapeutic options for patients with SNSCC.